Please....Vyvanse's patent goes until 2023, there's a new mg strength coming, a new indication, a chewable, a drug launch....no i don't see any need for ADHD reps?? Sounds logical with all of this coming....right
I work for AbbVie. When we acquired Solvay, those people did not get AbbVie pensions, because they did not have pensions with Solvay.
I'm only speculating, but if you have a pension plan with Shire, it would seem likely Abbvie would honor and continue to extend it. If Shire has not offered you a pension in the past, it doesn't seem like you Abbvie would offer ya'll a pension plan...
That's how it worked in the past with other mergers.